Spontaneous Pathological Complete Regression of Hepatocellular Carcinoma
نویسندگان
چکیده
منابع مشابه
Spontaneous Regression of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a malignant tumor frequently occurring in Koreans. It is well known that the prognosis of HCC is extremely poor. Most patients die within 3-6 months after diagnosis from gastrointest-inal hemorrhage, progress ive cachexia or liver failure 1). S pontaneous regression of HCC is a rare phenomenon and has, to our knowledge, been described in very few patients 2-8)....
متن کاملSpontaneous regression of hepatocellular carcinoma.
Spontaneous regression of cancer is a rare phenomenon seldom described in patients with hepatocellular carcinoma. A case of spontaneous regression of hepatocellular carcinoma is reported and compared with the reports published in the English literature. A 52-yr-old man presented with biopsy-proven hepatocellular carcinoma, which was considered to be unresectable at initial laparotomy. The tumor...
متن کاملSpontaneous complete necrosis of advanced hepatocellular carcinoma.
We present a rare case of hepatocellular carcinoma (HCC) in which spontaneous complete necrosis was confirmed with surgical resection. An 80-year-old man with HCC was referred to Nippon Medical School Tama Nagayama Hospital. The medical history included hypertension, managed with medication, and partial lobectomy of the lung owing to a lung schwannoma. A previously untreated abdominal aortic an...
متن کاملComplete Spontaneous Regression of Merkel Cell Carcinoma
I read the article "Complete spontaneous regression of Merkel cell carcinoma metastatic to the liver: Did lifestyle modifications and dietary supplements play a role?"(1) with great interest. Merkel cell carcinoma carries a significant rate of recurrence and mortality.(2) Though spontaneous regression of Merkel cell carcinoma has been well documented in the literature,(3) the potential that the...
متن کاملComplete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib
Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma (HCC) in Child-Pugh A patients. We describe the case of a patient who presented with a large HCC in the left liver associated with portal vein thrombosis (PVT). After 9 months of sorafenib treatment, reassessment showed that the tumors had decreased in size with recanalization of the port...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Gastroenterology
سال: 2018
ISSN: 1662-0631
DOI: 10.1159/000494551